08:00 , Mar 5, 2007 |  BioCentury  |  Emerging Company Profile

Corporate Profile

ApopLogic Pharmaceuticals Inc. Aurora, Colo. Technology: Apoptosis-inducing compounds Disease focus: Cancer Clinical status: Preclinical Founded: 2005 by Richard Duke, Donald Bellgrau and Jaime Modiano University collaborators: University of Colorado Corporate partners: None Number of employees:...
08:00 , Mar 5, 2007 |  BioCentury  |  Emerging Company Profile

ApopLogic: Finding cell death drivers

Although many cancer therapeutics ultimately work by instigating events that lead to apoptosis, ApopLogic Pharmaceuticals Inc. believes it can be successful by more directly focusing on the receptors and ligands involved in natural cell death....